Delivery Order SPE2DR25D2007-SPE2DR26FM30M
Award Date 12/22/25
Potential Completion Date 12/23/25
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,319.30 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis. Issued on December 9, 2025, with an ultimate completion date of December 10, 2025, this firm fixed-price contract reflects a routine medical supply procurement executed through a competitive process with no set-aside designation. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $9,760.98 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used primarily for treating plaque psoriasis and psoriatic arthritis. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,832.19 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used to treat plaque psoriasis and psoriatic arthritis. This non-competitive delivery order reflects a firm fixed price arrangement with an ultimate completion date of August 22, 2025, and represents a single transaction within the company's broader federal pharmaceutical supply network. The award was issued from...
- The Defense Logistics Agency awarded a delivery order valued at $2,691.01 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used to treat psoriasis and psoriatic arthritis. This competitively awarded, firm fixed-price delivery order was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,613.25 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used in the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis. This competitively awarded, firm fixed-price contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract...
- The Defense Logistics Agency awarded a $18,220.85 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used in the treatment of psoriasis and psoriatic arthritis. This firm fixed-price, non-competitive delivery order was executed on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of 60 tablets of Otezla 30 mg, a medication used to treat plaque psoriasis and psoriatic arthritis. This firm fixed-price delivery order, valued at $31,613.75, is scheduled for completion by September 26, 2025, and represents a non-competitive award utilizing the contractor's existing indefinite delivery contract vehicle. The order will be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $18,874.86 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 20, 2025, with a completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $34,797 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used to treat psoriasis and psoriatic arthritis. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which represents a child...
- The Defense Logistics Agency awarded a $3,934.86 delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for 60 tablets of Otezla 30 mg, a prescription medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by May 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a competitive award to the...